CEO Andrew Simpson on what’s ahead and how we’re applying advanced science and artificial intelligence to the ECG to make it a much more valuable screening tool

"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nCEO Andrew Simpson on what’s ahead and how we’re applying advanced science and artificial intelligence to the ECG to make it a much more valuable screening tool\nJanuary 31, 2023\n\nTo see the video, follow the link:  https://proactiveinvestors.com/companies/news/1004693/heartsciences-using-technology-to-help-make-lifesaving-ecg-s-better-using-artificial-intelligence-1004693.html?viewSource=SkyAlphabet\n\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n